首页|重症肺炎患者血清IL-17及IL-12P70与CD64表达水平及其与预后的关系

重症肺炎患者血清IL-17及IL-12P70与CD64表达水平及其与预后的关系

扫码查看
目的 分析重症肺炎患者血清白细胞介素(IL)-17、IL-12P70、簇分化抗原64(CD64)水平与病情严重程度及预后的关系.方法 选取2021年1月-2023年6月绍兴文理学院附属医院收治的重症肺炎患者120例作为重症组,同期选取普通肺炎患者60例作为普通组;分析重症肺炎患者病原菌,采集患者入院24 h内静脉血5 ml,检测血清IL-17、IL-12P70、CD64,分析其与急性生理慢性健康评分(APACHE Ⅱ)的相关性;根据28 d疾病转归情况,比较不同预后患者血清IL-17、IL-12P70、CD64水平;受试者操作特征(ROC)曲线评估IL-17、IL-12P70、CD64对患者预后价值.结果 120例重症肺炎患者共分离病原菌138株,以革兰阴性菌为主;重症组血清IL-17、IL-12P70、CD64水平高于普通组(P<0.05);血清IL-17、IL-12P70、CD64水平与APACHE Ⅱ评分均呈正相关(r=0.437,0.367,0.482;P<0.05);120例重症肺炎患者28 d内死亡36例,存活84例,存活组患者血清IL-17、IL-12P70、CD64水平低于死亡组(P<0.05);ROC曲线分析显示,血清IL-17、IL-12P70、CD64及联合检测评估患者预后的曲线下面积(AUC)分别为0.722、0.681、0.680和0.843.结论 血清IL-17、IL-12P70、CD64在重症肺炎患者中明显升高,三者联合检测具有评估患者预后的价值.
Serum levels of IL-17,IL-12P70 and CD64 in patients with severe pneumonia and their relationship with prognosis
OBJECTIVE To analyze the correlation of serum interleukin(IL)-17,IL-12P70,cluster differentiation antigen 64(CD64)levels with disease severity and prognosis of patients with severe pneumonia.METHODS A total of 120 patients with severe pneumonia and 60 patients with common pneumonia in the Affiliated Hospital of Sha-oxing University of Arts and Sciences between Jan 2021 and Jun 2023 were enrolled as the severe group and com-mon group,respectively.The distribution of pathogens in patients with severe pneumonia were analyzed.The ab-dominal venous blood of 5 ml was collected within 24 hours after admission,and the serum IL-17,IL-12P70 and CD64 levels were detected,and their correlation with score of acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ)was analyzed.According to disease outcomes on 28th day,serum levels of IL-17,IL-12P70 and CD64 among patients with different prognosis were compared.Receiver operating characteristic(ROC)curve was used to evaluate the prognostic value of IL-17,IL-12P70 and CD64 in prognosis.RESULTS A total of 138 strains of pathogenic bacteria were isolated from 120 patients with severe pneumonia,mainly gram-negative bacteria.The levels of serum IL-17,IL-12P70 and CD64 levels in the severe group were higher than those in the common group(P<0.05).The levels of serum IL-17,IL-12P70 and CD64 were positively correlated with APACHE Ⅱ score(r=0.437,0.367,0.482;P<0.05).Among 120 patients with severe pneumonia,36 died and 84 survived within 28 days.The serum levels of IL-17,IL-12P70 and CD64 in the survival group were lower than those in the death group(P<0.05).ROC curves analysis showed that area under curve(AUC)of individual and combined detection of serum IL-17,IL-12P70 and CD64 levels for evaluating prognosis of patients were 0.722,0.681,0.680 and 0.843,respectively.CONCLUSION The serum levels of IL-17,IL-12P70 and CD64 significantly increase in pa-tients with severe pneumonia,and their combined detection has high evaluation value for prognosis of patients.

Severe pneumoniaInterleukin-17Cluster differentiation antigen 64Disease severityPrognosis

蔡剑英、陶学芳、王国文、赵梁燕、孙永珍

展开 >

绍兴文理学院附属医院呼吸与危重症医学科,浙江绍兴 312000

重症肺炎 白细胞介素-17 簇分化抗原64 病情严重程度 预后

浙江省基础公益研究计划

LGF22H010004

2024

中华医院感染学杂志
中华预防医学会 中国人民解放军总医院

中华医院感染学杂志

CSTPCD北大核心
影响因子:1.885
ISSN:1005-4529
年,卷(期):2024.34(16)